CMS Targets Fee-for-Service Fragmentation in New 2027 Policy Roadmap
- Badari Andukuri
- Jul 19
- 2 min read
The Centers for Medicare & Medicaid Services (CMS) has unveiled a comprehensive, three-pillar strategy aimed at fundamentally restructuring Original Medicare (OM) by transitioning away from traditional, fragmented fee-for-service payment models.
The new framework seeks to optimize spending efficiency, expand patient-centric decision-making, and strengthen provider accountability within the Medicare Shared Savings Program. This initiative reflects the agency’s intensified focus on modernizing payment structures to curb expenditures for both taxpayers and beneficiaries.
Key Regulatory Proposals
Central to the 2027 strategy is a transition toward data-driven payment accuracy. CMS is moving away from strictly administrative pricing, increasingly utilizing empiric evidence and private-sector market data to calibrate rates. This shift includes active efficiency adjustments, such as those applied to surgical anesthesia billing, and a mandate to eliminate unreasonable payment differentials between independent physician offices and hospital outpatient departments.
In an effort to promote clinical accountability and operational efficiency, CMS is implementing reforms for Accountable Care Organizations (ACOs). The agency intends to permit ACOs to waive cost-sharing requirements for select Part B services, incentivizing the delivery of high-value care. Concurrently, the proposal targets a reduction in administrative burdens through enhanced data interoperability, the adoption of digital quality measures, and the integration of real-time claims processing.
Finally, the Shared Savings Program is undergoing significant structural updates. CMS proposes smoothing risk corridors to facilitate broader participation among new organizations and adjusting performance benchmarks to prevent the "ratchet effect," which has historically penalized successful ACOs by escalating targets.
Data-Driven Payment Accuracy
CMS is moving beyond traditional administrative pricing by integrating real-world evidence. A recent study on anesthesia duration revealed that previous estimates were roughly 20% higher than actual time spent in surgery. In response, the 2026 Physician Fee Schedule (PFS) includes new efficiency adjustments. The agency is also incorporating private payer rate data for laboratory services and hospital-negotiated rates with Medicare Advantage to better reflect market conditions.
Reducing Payment Disparities and Over-Medicalization
To curb unnecessary growth in service volume and hospital consolidation, CMS is addressing payment differentials between various care settings. Notably, drug administration services in off-campus outpatient hospital departments now match PFS-equivalent rates, a move projected to save beneficiaries $6 billion over the next decade. Furthermore, CMS is refining bundling policies to prevent duplicate payments for procedures and office visits occurring on the same day, while also exploring new models to bundle chronic care drugs.
Embracing Technology and Transparency
CMS is actively establishing new pricing pathways for emerging digital health solutions. The 2027 proposed rules include rate updates for remote monitoring services and the formal recognition of Software as a Medical Service (SaMS) to support clinical decision-making. Simultaneously, the agency is seeking to standardize hospital price transparency data, aiming to make it easier for consumers to compare costs across different facilities.
Industry Context
This policy pivot represents an urgent push to stabilize Medicare’s long-term fiscal health by prioritizing quality outcomes over service volume. By reimagining primary care and exploring new bundling opportunities, the agency aims to foster a more sustainable, outcomes-focused healthcare system. Industry observers note that the organizations poised to succeed in the coming decade will be those that prioritize technological integration, operational efficiency, and business models that align with the agency’s objective of enhancing patient health outcomes through evidence-based care.

Comments